| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K44224150 |
| PharmacoGx | BRD-K44224150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SYNGR4 | CTRPv2 | pan-cancer | AAC | 0.51 | 3e-14 |
| mRNA | PABPC5 | CTRPv2 | pan-cancer | AAC | 0.53 | 2e-07 |
| mRNA | C1QTNF2 | CTRPv2 | pan-cancer | AAC | 0.54 | 0.0004 |
| mRNA | FNDC5 | CTRPv2 | pan-cancer | AAC | 0.59 | 0.0003 |
| mRNA | PON1 | CTRPv2 | pan-cancer | AAC | 0.84 | 0.0007 |
| mRNA | GK2 | CTRPv2 | pan-cancer | AAC | 1.3 | 7e-07 |
| mRNA | SBK2 | CTRPv2 | pan-cancer | AAC | 1.6 | 2e-07 |
| mRNA | TACR3 | CTRPv2 | pan-cancer | AAC | 2.1 | 0.0002 |
| mRNA | MYBPHL | CTRPv2 | pan-cancer | AAC | 2.6 | 0.007 |
| mRNA | KLHL40 | CTRPv2 | pan-cancer | AAC | 8.4 | 8e-06 |
